A Study on CBD and Δ9-THC Analysis and Telemedicine of Korean Hemp Seed Foods Manufactured by Oriental Medicine Method

Abstract

Background Despite the UN's recommendation to abolish restrictions on Cannabidiol (CBD) in the medical and recreation sectors, detailed regulations worldwide on food-grade CBD & Tetrahydrocannabinol (THC) are not adequately reflected. Methods The methods of extracting hemp, which was practiced for thousands of years as detailed in ancient oriental medicine literature, were compared with recent Western cannabis case studies, and the possibility of delivering the extracts through food via telemedicine was evaluated. After decades of research, attempts have been made to use improvised hemp or cannabis for medical and cosmetic purposes with lower CBD and THC content, but micro-components, including CBD and THC analysis of Korean hemp seeds(Cheong-Sam), have yet to be accurately reported. Results The CBD and THC contents of Korean hemp seeds were measured within the HPLC 300 measurement range and analyzed by diluting 10 times or more to imitate the projected concentration in food. The CBD/THC content of Korean hemp seeds produced in the Andong Hemp Special Zone (AHSZ) was extracted by either hot water extraction or cold compression, similar to traditional medical literature, and then analyzed thoroughly to examine the applicability of traditional oriental methods to food. Conclusion CBD and THC contents were safe at less than 3 ppm when using Korean hemp. In the method extracted from the literature, CBD, Δ 9 -THC, tetrahydrocannabinolic acid (THCA), Cannabidiolic acid (CBDA), Cannabidivarinic acid(CBDVA), Cannabigerolic acid (CBGA), Tetrahydrocannabivarin acid (THCVA) responding to human reaction mechanisms were not detected in foods containing Korean hemp (Cheong-Sam) seed and oil used in this study.